- Asked by: Willie Rennie, MSP for North East Fife, Scottish Liberal Democrats
-
Date lodged: Thursday, 19 February 2026
-
Current Status:
Answered by Jenni Minto on 26 February 2026
To ask the Scottish Government what funding it plans to make available for research into lobular breast cancer, and what its position is on whether such research funding should be proportionate to the prevalence of the condition.
Answer
The Scottish Government’s Chief Scientist Office (CSO) supports applied health research in Scotland through open competitive grant and fellowship schemes with a wide remit inclusive of research across the range of clinical conditions including types of cancers. Funding through these schemes is not specifically allocated to specific conditions so as not to constrain the range of research that can be funded. Applications submitted to these schemes are assessed through independent expert peer-review with funding recommendations made by independent expert committees. CSO also contributes financially to the National Institute of Health & Care Research (NIHR) in order that researchers in Scotland can apply to NIHR research programmes. NIHR recently issued a highlight notice to encourage applications for “high quality studies on Invasive Lobular Carcinoma (ILC) or lobular breast cancer".